Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2018-09-19 Tx date 2018-09-17 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
$30,000
+200,000 vol $0.15 each |
135,000 | |
Filed 2018-09-19 Tx date 2018-09-17 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-30,000
-200,000 vol $0.15 each |
-65,000 | |
Filed 2018-06-27 Tx date 2018-06-26 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$146,200
+1,000,000 vol $0.1462 each |
10,293,311 | |
Filed 2018-06-27 Tx date 2018-06-26 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$545,376
+4,277,465 vol $0.1275 each |
14,570,776 | |
Filed 2018-06-21 Tx date 2018-06-19 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
47 - Acquisition or disposition by gift
|
-1,500,000 vol |
||
Filed 2018-06-21 Tx date 2018-06-19 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-170,000
-1,000,000 vol $0.17 each |
9,293,311 | |
Filed 2018-06-21 Tx date 2018-06-19 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
47 - Acquisition or disposition by gift
|
-500,000 vol |
10,293,311 | |
Filed 2018-06-19 Tx date 2018-06-19 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
47 - Acquisition or disposition by gift
|
-1,500,000 vol |
9,293,311 | |
Filed 2018-03-15 Tx date 2018-03-12 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$810,000
+3,000,000 vol $0.27 each |
10,793,311 | |
Filed 2018-02-14 Tx date 2018-02-13 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$1,181,250
+4,500,000 vol $0.2625 each |
5,587,488 | |
Filed 2018-01-17 Tx date 2018-01-16 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$122,743
+762,379 vol $0.161 each |
7,793,311 | |
Filed 2017-12-20 Tx date 2017-12-18 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$15,749
+36,627 vol $0.43 each |
7,030,932 | |
Filed 2017-12-19 Tx date 2017-12-18 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
+200,000 vol |
335,000 | |
Filed 2017-12-19 Tx date 2017-12-18 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-200,000 vol |
135,000 | |
Filed 2017-12-13 Tx date 2017-12-12 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-30,360
-66,000 vol $0.46 each |
1,087,488 | |
Filed 2017-12-06 Tx date 2017-12-06 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
47 - Acquisition or disposition by gift
|
-1,046,667 vol |
6,994,305 | |
Filed 2017-10-31 Tx date 2017-10-30 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$13,745
+99,099 vol $0.1387 each |
8,040,972 | |
Filed 2017-09-12 Tx date 2017-09-11 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Options
50 - Grant of options
|
$145,000
+1,000,000 vol $0.145 each |
2,885,000 | |
Filed 2017-09-12 Tx date 2017-09-11 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$5,247
+48,275 vol $0.1087 each |
7,941,873 | |
Filed 2017-09-12 Tx date 2017-09-11 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$14,499
+100,000 vol $0.145 each |
7,893,598 | |
Filed 2017-08-30 Tx date 2017-08-24 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$23,000
+200,000 vol $0.115 each |
7,993,598 | |
Filed 2017-08-30 Tx date 2017-08-24 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
47 - Acquisition or disposition by gift
|
-200,000 vol |
7,793,598 | |
Filed 2017-08-30 Tx date 2017-08-24 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$5,246
+60,869 vol $0.0862 each |
7,793,598 | |
Filed 2017-07-17 Tx date 2017-07-12 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$5,247
+48,275 vol $0.1087 each |
7,732,729 | |
Filed 2017-07-17 Tx date 2017-07-12 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$72,500
+500,000 vol $0.145 each |
7,684,454 | |
Filed 2017-06-17 Tx date 2017-06-12 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$92,500
+500,000 vol $0.185 each |
7,684,454 | |
Filed 2017-06-17 Tx date 2017-06-12 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-92,500
-500,000 vol $0.185 each |
7,184,454 | |
Filed 2017-06-15 Tx date 2017-06-12 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$5,247
+37,837 vol $0.1387 each |
7,184,454 | |
Filed 2017-04-25 Tx date 2015-03-17 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$26,000
+200,000 vol $0.13 each |
1,053,488 | |
Filed 2017-04-25 Tx date 2017-04-20 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-65,000 vol |
135,000 | |
Filed 2017-04-25 Tx date 2015-03-11 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
+200,000 vol |
200,000 | |
Filed 2017-04-25 Tx date 2017-04-20 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$117,966
+669,504 vol $0.1762 each |
7,146,617 | |
Filed 2017-04-16 Tx date 2017-04-12 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$80,250
+535,000 vol $0.15 each |
6,477,113 | |
Filed 2017-03-15 Tx date 2017-03-13 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$10,504
+90,322 vol $0.1163 each |
5,942,113 | |
Filed 2017-03-15 Tx date 2017-03-10 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-30,000
-200,000 vol $0.15 each |
5,936,791 | |
Filed 2017-03-15 Tx date 2017-03-10 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-13,175
-85,000 vol $0.155 each |
5,851,791 | |
Filed 2017-03-15 Tx date 2017-03-10 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Options
51 - Exercise of options
|
$-42,000
-700,000 vol $0.06 each |
1,050,000 | |
Filed 2017-03-15 Tx date 2017-03-10 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Options
51 - Exercise of options
|
$42,000
+700,000 vol $0.06 each |
1,750,000 | |
Filed 2017-01-26 Tx date 2017-01-23 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Warrants
54 - Exercise of warrants
|
$21,000
+300,000 vol $0.07 each |
555,556 | |
Filed 2017-01-26 Tx date 2017-01-23 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Warrants
54 - Exercise of warrants
|
$-21,000
-300,000 vol $0.07 each |
255,556 | |
Filed 2017-01-26 Tx date 2017-01-23 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$5,237
+51,852 vol $0.101 each |
6,136,791 | |
Filed 2017-01-15 Tx date 2017-01-12 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-28,000
-200,000 vol $0.14 each |
953,488 | |
Filed 2017-01-15 Tx date 2017-01-12 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,000
+200,000 vol $0.09 each |
1,153,488 | |
Filed 2017-01-15 Tx date 2017-01-09 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
+200,000 vol |
0 | |
Filed 2017-01-15 Tx date 2017-01-09 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-200,000 vol |
-200,000 | |
Filed 2017-01-09 Tx date 2016-08-02 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
36 - Conversion or exchange
|
$46,259
+925,186 vol $0.05 each |
4,987,343 | |
Filed 2016-12-19 Tx date 2016-12-12 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$5,249
+53,846 vol $0.0975 each |
5,159,753 | |
Filed 2016-11-18 Tx date 2016-11-14 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$5,250
+43,750 vol $0.12 each |
5,105,907 | |
Filed 2016-10-24 Tx date 2016-06-30 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$875.00
+25,000 vol $0.035 each |
2,816,766 | |
Filed 2016-10-24 Tx date 2016-10-14 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Options
50 - Grant of options
|
+1,750,000 vol |
1,750,000 | |
Filed 2016-10-24 Tx date 2016-10-14 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$117,800
+950,000 vol $0.124 each |
5,062,157 | |
Filed 2016-10-24 Tx date 2016-10-14 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$3,100
+25,000 vol $0.124 each |
4,112,157 | |
Filed 2016-10-24 Tx date 2016-09-20 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$1,405
+25,000 vol $0.0562 each |
4,087,157 | |
Filed 2016-10-24 Tx date 2016-08-02 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$61,019
+1,220,391 vol $0.05 each |
4,062,157 | |
Filed 2016-10-24 Tx date 2016-07-31 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$875.00
+25,000 vol $0.035 each |
2,841,766 | |
Filed 2016-06-06 Tx date 2016-05-24 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,500
+100,000 vol $0.045 each |
953,488 | |
Filed 2016-06-01 Tx date 2016-05-31 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$1,250
+25,000 vol $0.05 each |
2,791,766 | |
Filed 2016-05-06 Tx date 2016-05-03 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$1,250
+25,000 vol $0.05 each |
2,766,766 | |
Filed 2016-04-08 Tx date 2016-04-08 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$165.00
+3,000 vol $0.055 each |
2,741,766 | |
Filed 2016-04-08 Tx date 2016-04-07 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,460
+172,000 vol $0.055 each |
2,738,766 | |
Filed 2016-04-05 Tx date 2016-04-01 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$1,500
+25,000 vol $0.06 each |
2,566,766 | |
Filed 2016-03-04 Tx date 2016-02-29 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
+25,000 vol |
2,541,766 | |
Filed 2015-08-24 Tx date 2015-08-20 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Options
50 - Grant of options
|
$42,000
+700,000 vol $0.06 each |
1,885,000 | |
Filed 2015-08-24 Tx date 2015-08-18 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$1,750
+25,000 vol $0.07 each |
2,516,766 | |
Filed 2015-07-20 Tx date 2015-05-06 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$14,000
+116,667 vol $0.12 each |
2,343,100 | |
Filed 2015-07-20 Tx date 2015-07-03 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,893
+98,666 vol $0.08 each |
2,491,766 | |
Filed 2015-07-20 Tx date 2015-07-03 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$1,625
+25,000 vol $0.065 each |
2,393,100 | |
Filed 2015-07-20 Tx date 2015-06-03 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$2,750
+25,000 vol $0.11 each |
2,368,100 | |
Filed 2015-07-20 Tx date 2015-06-03 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$27,500
+250,000 vol $0.11 each |
||
Filed 2015-07-20 Tx date 2015-03-04 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$34,375
+196,429 vol $0.175 each |
2,172,985 | |
Filed 2015-06-03 Tx date 2015-06-03 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$27,500
+250,000 vol $0.11 each |
2,280,004 |